Zephyrnet Logo

Tag: SaNOtize

[SaNOtize in Business Wire] SaNOtize announces inaugural scientific advisory board

VANCOUVER, British Columbia–(BUSINESS WIRE)–SaNOtize Research and Development Corp. (“SaNOtize”), a Canadian anti-infective-focused therapeutics company, today announced the formation of its inaugural scientific advisory board...

Top News

Newsletter: $110M raised by OurCrowd startups

Top investment opportunitiesStartup of the Week: SynergyMed, transforming surgery with 3D printing and visualizationWomen tech leaders in the spotlight at OurCrowd SummitOurCrowd in UAE:...

[SaNOtize in South China Morning Post] Li Ka-shing’s Horizons Ventures makes undisclosed investment in Canadian Covid-19 treatment start-up SaNOtize

Horizons and Jerusalem-based OurCrowd lead US$24 million Series B funding round Funding will go towards the expansion of a third-phase clinical trial of a nasal...

[SaNOtize in Business Wire] SaNOtize announces $24 million in Series B funding to advance its nitric oxide-based therapeutics, including nasal spray for the treatment...

VANCOUVER, British Columbia–(BUSINESS WIRE)–SaNOtize Research & Development Corp., (“SaNOtize”), a Canadian anti-infective-focused therapeutics company, today announced an oversubscribed $24 million Series B funding to...

[SaNOtize in Financial Express] Glenmark Pharmaceuticals and SaNOtize announce their Phase 3 Clinical Trials results on novel nasal spray for COVID-19

The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of...

[PRESS RELEASE] Newly Published Phase 3 Study in People with COVID-19 Shows SaNOtize Nitric Oxide Nasal Spray Reduced Viral Load by 99% within Two...

VANCOUVER, British Columbia & MUMBAI, July 13, 2022–SaNOtize Research & Development Corp., (“SaNOtize”), a Canadian anti-infective-focused therapeutics company, and Glenmark Pharmaceuticals Limited (“Glenmark”), a...

[SaNOtize in Business Wire] Clinical study suggests SaNOtize nitric oxide nasal spray is effective at preventing COVID-19 after high-risk exposure

VANCOUVER, British Columbia–(BUSINESS WIRE)–SaNOtize Research and Development (“SaNOtize”) today announced results from a retrospective clinical study assessing the efficacy of nitric oxide releasing nasal...

[SaNOtize in NoCamels] SaNOtize ramps up anti-Covid nasal spray production to keep up with demand

SaNOtize CEO Dr. Gilly Regev visited Israel earlier this month as she inspected the increase in manufacturing production of her company’s antiviral nasal...

[SaNOtize in TrialSiteNews] Nasal spray stops COVID-19 in use in Israel & Bahrain—why isn’t this reported in America

At the start of 2021 TrialSite reported on UK-based NHS hospitals involved with a clinical trial involving a nasal spray that in a...

[SaNOtize in Times of india] GMCH to host nasal spray trials to treat Covid-19 patients

ANAMA — Bahrain has authorized a clinical study to evaluate the use of Enovid nasal spray to treat individuals with COVID-19. The authorization...

[SaNOtize in Saudi Gazette] Bahrain authorizes use of nasal spray to treat and prevent COVID-19

ANAMA — Bahrain has authorized a clinical study to evaluate the use of Enovid nasal spray to treat individuals with COVID-19. The authorization...

Newsletter: Quantum encryption + OurCrowd-Azerbaijan MoU

Startup of the Week: QuantLR, low-cost quantum encryption Azerbaijan Investment Co. signs with OurCrowd FDA clears RealView hologram for ‘sci-fi’ surgical planning Nexa3D’s ‘Nexa Level’...

[SaNOtize in Business Wire] SaNOtize inks agreement with Indian biotech Glenmark to commercialize Nitric Oxide Nasal Spray for COVID-19 treatment in India and other...

VANCOUVER, British Columbia & MUMBAI, India–(BUSINESS WIRE)–SaNOtize Research and Development Corp. and Indian company, Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today...

Latest Intelligence

spot_img
spot_img